In AML with myelodysplasia-related changes (AML-MRC), dysplastic multi-lineage morphology is enriched for TP53 mutations, and survival remains < 6 months despite intensive chemotherapy [79,241]. Here, TP53 is linked to acute myeloid leukemia.